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The objective of this study was to determine antioxidant and cytotoxic eﬃcacies of methanolic and aqueous extracts of Rheum
emodi Wall. ex Meissn. rhizome. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radical scavenging activities, inhibitory
eﬀect on lipid peroxidation and Fe3+ reducing antioxidant property have been used to investigate antioxidant properties of
the extracts. Cytotoxicity of the extracts was tested on MDA-MB-435S and Hep3B cell lines. Both extracts displayed extensive
cytotoxicity to the tested cell lines. The extracts were studied for their ability to protect pBR322 DNA from damage by UV induced
photolysis of H2O2. The aqueous extract, though inferior to methanolic extract in its antioxidant potential exhibited eﬃciency in
DNA protection, while the methanolic extract failed to protect the DNA. The amount of total polyphenolics in the extracts was
measured by spectrophotometric method. The methanolic extract contained higher polyphenolic contents than aqueous extract.
Signiﬁcant positive correlations were observed (P < .05) between results of phenolic content estimation and that of antioxidant
assays. Hence, high-performance liquid chromatography analysis was performed to identify few major phenolic compounds that
might be responsible for these therapeutic properties. These results indicate that rhizome of R. emodi possesses antioxidant and
cytotoxic activities and therefore have therapeutic potential.
1.Introduction
Cancer chemoprevention is deﬁned as the use of natural,
synthetic or biologic chemical agents to reverse, suppress,
or prevent carcinogenic progression [1] .T h e r eh a v eb e e n
increasing safety concerns over synthetic chemopreventive
therapy. Commonly used synthetic antioxidants like buty-
lated hydroxyanisole (BHA) and butylated hydroxyltoluene
(BHT) have been restricted due to their toxicity and DNA
damage induction potential [2, 3]. Instead, ﬂoral resources
havereceivedconsiderableattentionassourcesofbiologically
active substances including antioxidants, anti-mutagens and
anti-carcinogens [4].
Rheum emodi Wall. ex Meissn. (Polygonaceae) is a leafy
perennial herb distributed in altitudes ranging from 2800
to 3800m in the temperate and subtropical regions of
Himalayas from Kashmir to Sikkim in India [5]. Roots of
R. emodi are reported to have antibacterial and antifungal
activities [6–10]. In addition several other biological activ-
ities such as laxative, diuretic, and in vivo inhibitory eﬀect
towards P388 leukemia in mice are also reported [11–13].
The aim of this study was to determine the antioxidant
andanti-cancerpotentialofmethanolicandaqueousextracts
of R. emodi rhizome by various methods including 2,2-
diphenyl-1-picrylhydrazyl (DPPH) and •OH radical scav-
enging, Fe3+ reducing capacity and inhibition of lipid
peroxidation in vitro which are rarely reported. Cytotoxicity
of the extracts were determined in MDA-MB-435S (human
breast carcinoma) and Hep3B (liver carcinoma) cell lines.
The protective activity of the extracts was evaluated by UV
induced photolysis of H2O2 leading to damage to pBR322
DNA. Total phenolic content estimation was performed, and
a few phenolic compounds that might be responsible for the
antioxidant property of the extracts were identiﬁed by high-
performance liquid chromatography (HPLC).
2. Methods
2.1. Chemicals and Other Reagents. DPPH, thiobarbituric
acid(TBA),ethylene diamine tetraacetic acid (EDTA),ascor-
bic acid, trichloroacetic acid (TCA), phenazine methosulfate2 Evidence-Based Complementary and Alternative Medicine
(PMS) (also known as N-methylphenazonium methosul-
fate), dimethyl sulfoxide (DMSO), L-15 (Leibovitz) cell cul-
ture medium (with l-glutamine), MEM (minimal essential
medium) cell culture medium (with Earle’s salt, NEAA
and l-glutamine) and 2,4,6-tripyridyl-s-triazine (TPTZ)
were purchased from Himedia Laboratories Pvt. Ltd.
(India). XTT {2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino) carbonyl]-2H-tetrazolium hydroxide} was
obtained from Sigma Chemical Co. (St. Louis, MO, USA).
Folin-Ciocalteau reagent was procured from Sisco Research
Lab(India).Theremainingchemicalsandsolventsusedwere
of standard analytical grade and HPLC grade, respectively.
pBR322 was purchased from Medox Biotech India Pvt.
Ltd. (India). MDA-MB-435S (human breast carcinoma) and
Hep3B (human liver carcinoma) cell lines were obtained
from National Centre for Cell Science (Pune, India).
2.2. Plant Material. Rheum emodi rhizomes were collected
from their natural habitat in the Garhwal Himalayas at
Chamoli (30◦ 24  N, 79◦ 21  E), Uttaranchal, India in the
month of June, 2007. Collected specimen were shade-
dried, powdered and used for solvent extraction. Voucher
specimen were maintained at our laboratory for future
reference (Accession no.: VIT/SBCBE/CCL/07/6/04; Dated:
June 11, 2007).
2.3. Extraction. Rhizome powder was serially extracted with
methanol and water using a Soxhlet apparatus in a ratio
of 1:6 [powder (in grams):solvent (in milliliters)]. The
extract obtained was evaporated to dryness at 40◦Cu n d e r
reduced pressure (methanol: 337 mbar, aqueous: 72 mbar
in a rotary evaporator (B¨ Uchi, Switzerland). Fifty grams of
rhizome powder yielded 24.81g (percentage extract yield:
49.62% of dry weight) of crude methanolic extract and
3.86g (percentage extract yield: 7.72% of dry weight) of
crude aqueous extract. The samples were stored in a vacuum
dessicator at room temperature until further use.
2.3.1. DPPH Radical Scavenging Activity. Free radical scav-
enging ability of the extracts was tested by DPPH radical
scavenging assay (DRSA) as described by Blois [14]. An
amount of 20, 40, 60, 80 and 100μg of the extracts were
taken in test tubes and made up to 0.5ml with the respective
solvents. An amount of 3ml 0.1mM DPPH• in ethanol
was added to each tube and incubated in dark at room
temperature for 30min. Absorbance was read at 517nm
using a Cary 50 UV-Vis Spectrophotometer (Varian Inc.,
Australia). Percentage DPPH radical scavenging activity (%
DRSA) was calculated using the formula,
%DRSA =

Ac −A
Ac

×100, (1)
where Ac is the absorbance of the control and A is the
absorbance of the extract.
2.3.2. Hydroxyl Radical Scavenging Activity. •OH radical
scavenging activity (HRSA) of the extracts was estimated
by the method of Klein et al. [15]. An amount of 50, 100,
150 and 200μg of the extracts were taken in test tubes.
An amount of 1ml iron-EDTA solution (0.13% ferrous
ammonium sulfate and 0.26% EDTA), 0.5ml of 0.018%
EDTA and 1ml of 0.85% (v/v) DMSO (in 0.1M phosphate
buﬀer,pH7.4)wereaddedfollowedby0.5mlof0.22%(w/v)
ascorbic acid. The tubes were capped tightly and incubated
on a water bath at 85◦C for 15min. Post-incubation, the
test tubes were uncapped and ice-cold trichloroacetic acid
(17.5% w/v) was added in each immediately. An amount of
3ml Nash reagent (7.5g of ammonium acetate, 300μlg l a c i a l
acetic acid and 200μla c e t y la c e t o n ew e r em i x e da n dm a d e
up to 100ml with distilled water) was added to all the tubes
and incubated at room temperature for 15min. Absorbance
was measured at 412nm.
Percentagehydroxylradicalscavengingactivity(%HRSA)
was calculated by the following formula:
%HRSA =

Ac −A
Ac

×100, (2)
where Ac is the absorbance of the control and A is the
absorbance of the extract.
2.3.3. Ferric Reducing Antioxidant Property. Ferric reducing
antioxidantproperty(FRAP)assaywasdoneaccordingtothe
protocol of Benzie and Strain [16] with some modiﬁcations.
The stock solutions were 300mM acetate buﬀer (with 16ml
C2H4O2; pH 3.6), TPTZ solution (10mM TPTZ in 40mM
HCl) and 20mM FeCl3·6H2O solution. Working FRAP
solution was prepared freshly by mixing 25ml of acetate
buﬀer, 2.5ml TPTZ solution and 2.5ml of FeCl3·6H2O
solution, and then warmed to 37◦C before use. An amount
of 150μl individual extract solutions (containing 25, 50,
100 and 200μg of extracts, resp.) was allowed to react with
2.85ml of FRAP solution for 30min in dark. Absorbance
was read at 593nm. Percentage Fe3+ reduction (to Fe2+)w a s
calculated by a FeSO4 standard calibration curve. Percentage
scavenging was also evaluated in ascorbic acid equivalence
(AAE) (in micrograms).
2.3.4. Thiobarbituric Acid Assay. The assay was performed
as described by Halliwell and Gutteridge [17], in which
the extent of lipid peroxidation was estimated from the
concentration of malondialdehyde (MDA), a thiobarbituric
acid reactive substance (TBARS), which is produced due to
lipid peroxidation. A 6-week-old female Wistar albino rat
weighing ∼150g was sacriﬁced under ethereal anesthesia
and its liver was excised. 10% (w/v) liver homogenate was
prepared in Dulbecco’s phosphate buﬀered saline (PBS)
(Ca2+/Mg2+-free) (pH 7.4), and centrifuged at 503g for
1 5 m i nt oo b t a i nac l e a rs u p e r n a t a n t .A na m o u n to f5 0 ,
100, 150, 200 and 250μg of the extracts were taken in test
tubes and were evaporated to dryness at 80◦C. An amount
of 1ml 0.15M potassium chloride was added to the tubes
followedby0.5mlofratliverhomogenate(10%w/vinPBS).
Peroxidation was initiated by the addition of 100μlo f2m M
ferricchloride.Afterincubatingthetubesfor30minat37◦C,
the peroxidation reaction was stopped by adding 2ml of ice-
coldHCl(0.25N)containing15%TCAand0.38%TBA.TheEvidence-Based Complementary and Alternative Medicine 3
tubes were kept at 80◦Cf o r1h ,c o o l e da n dc e n t r i f u g e da t
3144g. The absorbance of the supernatant, containing TBA-
MDA complex was read at 532nm. Percentage inhibition of
lipid peroxidation (%LPI) was calculated using the formula,
%LPI =

Ac −A
Ac

×100, (3)
where Ac is the absorbance of the control and A is the
absorbance of the extract.
This experiment was performed according to the guide-
lines of the “European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other Scientiﬁc
Purposes” (and its appendix) with the approval of the insti-
tutional animal ethical committee (PSGIMSR/27.02.2008).
2.3.5. XTT Assay. XTT assay was performed on MDA-MB-
435S (grown in L-15 medium) and Hep3B (grown in MEM
medium) cell lines as described by Weislow et al. [18]. A
total of 6 × 103 cells were seeded on 96-well plates and were
supplemented with 200μl of the respective culture media for
a period of 24 h. The media were then substituted by 200μl
of fresh media containing varying concentrations of the
extracts (15.625, 31.25, 62.5 and 125μg/ml). The plates were
incubated at 37◦C for 24 h, after which, media was removed
and fresh media added. An amount of 50μlX T Tr e a g e n t
prepared in respective media (0.6 mg/ml) containing 25μM
of PMS was then added to all the wells, and the plates were
incubated in dark humid conditions at 37◦Cf o r4h .A f t e r
incubation, the orange colored complex formed was read at
450nm using a Dynex Opsys MR Microplate Reader (Dynex
Technologies, VA, USA) with a 630nm reference ﬁlter. Wells
containing cells without extract treatments served as the
control. Wells containing only culture medium and XTT
reagent served as the blank. Percentage cytotoxicity of the
extracts was calculated by using the formula:
%Cytotoxicity =

Ac −A
Ac

×100, (4)
where Ac is the absorbance of the control and A is the
absorbance of the sample.
2.4. DNA Damage Inhibition Eﬃciency. Potential DNA dam-
age inhibition by R. emodi extracts was tested by photolysing
H2O2 by UV radiation in presence of pBR322 plasmid DNA
and performing agarose gel electrophoresis with the irradi-
atedDNA[19].Atotalof1μlaliquotsofpBR322(200μg/ml)
weretakeninUVnon-resistantpolyethylenemicrocentrifuge
tubes. A quantity of 50μg of each extract was separately
added to two tubes. The remaining tube was left untreated as
the irradiated control (CR). An amount of 4μlo f3 %H 2O2
was added to all the tubes which were then placed directly on
the surface of a UV transilluminator (300nm). The samples
were irradiated for 10min at room temperature. After
irradiation, 4μl of tracking dye (0.25% bromophenol blue,
0.25% xylene cyanol FF and 30% glycerol) was added. The
samples in alltubes were then analyzed by gelelectrophoresis
on a 1% agarose gel in TBE buﬀer (pH 8). Untreated non-
irradiated pBR322 plasmid (C) was run along with the
extract-treated UV-irradiated samples (methanolic extract
treated =SM andaqueousextracttreated =SA)anduntr eat ed
UV-irradiated (CR) plasmid DNA. The gel was stained in
ethidium bromide (1μg/ml; 30min) and photographed on
Lourmat Gel Imaging System (Vilbar, France).
2.4.1. Estimation of Total Phenolic Content. Total phenolic
content was determined by the method described by Lister
and Wilson [20]. An amount of 50, 100, 150, 200 and 250 of
the extracts were made up to 0.5ml with distilled water. An
amount of 2.5ml Folin-Ciocalteau reagent (1:10 dilution)
and2mlofsodiumcarbonate(7.5%w/v)wereaddedandthe
tubes incubated at 45◦C for 15min. Absorbance were read at
765nm using a Cary 50 UV-Vis spectrophotometer (Varian,
Inc., CA, USA). Results were expressed in terms of gallic acid
equivalence (GAE) in micrograms.
2.4.2. HPLC Analysis for Phenolic Compounds. HPLC anal-
ysis was performed using a Waters 2487 HPLC system
consisting of a dual λ detector and a Waters 1525 binary
pump, and equipped with a Waters Symmetry C18 column
(5μm, 4.6 × 150 mm) with Waters Sentry universal guard
column (5μm, 4.6 × 20 mm) (Waters Corporation, Mil-
ford, MA, USA). Phenolic compounds in the aqueous and
methanolic extracts of R. emodi were analyzed using the
library for phenolic compound standards [21] as a reference.
Gradient elution was performed at 35◦C with Solution A
(50mM sodium phosphate in 10% methanol; pH 3.3) and
Solution B (70% methanol) in the following gradient elution
program: 0–15min—100% of Solution A; 15–45min—70%
of Solution A; 45–65min—65% of Solution A; 65–70min—
60% of Solution A; 70–95min—50% of Solution A; 95–
100min—0% of Solution A. Flow rate was 1ml/min and
injection volume was 20μl. Detection was monitored at
diversewavelengths(aroundλmax)forvariousphenoliccom-
pounds, that is, 250nm for benzoic acids, isoﬂavones and
most anthraquinones; 280nm for some ﬂavones, ﬂavanones,
catechins, theaﬂavins and some anthraquinones; 320nm for
cinnamic acids, most ﬂavones and chalcones; 370nm for
ﬂavonols; 510nm for anthocyanins.
2.5. Statistical Analysis. All analyses were carried out in
triplicates. Data were presented as mean ± SD. Statistical
analyses were performed by one-way ANOVA. Signiﬁcant
diﬀerences between groups were determined at P < .05.
To evaluate relationships between experimental parameters,
results were analyzed for correlation and regression and
tested for signiﬁcance by Student’s t-test (P < .05). MATLAB
ver. 7.0 (Natick, MA, USA), GraphPad Prism 5.0 (San Diego,
CA, USA) and Microsoft Excel 2007 (Roselle, IL, USA) were
used for the statistical and graphical evaluations.
3. Results
3.1.DRSA. Bothextractsshowed aconcentrationdependent
scavenging of DPPH• radicals. Methanolic extract was found
to be more active radical scavenger than aqueous extract.
Results were plotted as %DRSA and also expressed as AAE
in micrograms (Figure 1).4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: %DRSA of methanolic and aqueous extracts of R. emodi
rhizome with AAE in micrograms. Data expressed as mean ± SD of
n = 3 samples (P < .05) for all tested dosages.
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Figure 2: Mean %HRSA of methanolic and aqueous extracts of R.
emodi rhizome (P < .05).
3.2. HRSA. The ability of the extracts to quench •OH rad-
icals can be related to the prevention of lipid peroxidation,
and it seems to be a good scavenger of active oxygen species,
thus reducing the rate of chain reaction. Figure 2 shows
%HRSA of the two extracts. Hydroxyl radical has been
implicated as highly damaging in free-radical pathology,
capable of damaging almost every molecule found in living
cells [22]. The extracts have shown a dosage-dependent
increase in inhibition of •OH radicals.
3.3. FRAP. Fe3+ reducing activity of the two extracts were
determined by FRAP assay. The methanolic extract showed
higher reducing power in comparison to the aqueous extract
for all tested dosages. Figure 3 shows %Fe3+ reduction by
both extracts along with AAE in micrograms.
3.4. TBA Assay. Both extracts were capable of preventing
formation of MDA in a dosage-dependent manner. The
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Figure 3: Percentage Fe3+ reduction by methanolic and aqueous
extracts of R. emodi rhizome with AAE in micrograms. Data
expressed as mean ± SD (n = 3, P < .05) for all tested dosages.
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Figure 4: %LPI by methanolic and aqueous extracts of R. emodi
rhizome with BHT equivalence in micrograms. Data expressed as
mean ± SD (n = 3, P < .05) for all dosages.
methanolic extract was observed to be a signiﬁcantly better
inhibitor of lipid peroxidation (at P < .05) compared
with the aqueous extract for all tested dosages. Figure 4
shows %LPI with their corresponding BHT equivalences (in
micrograms).
Signiﬁcant correlations (P < .05) were observed between
the following: (i) %LPI and %DRSA, (ii) %LPI and %HRSA
and (iii) %LPI and %Fe3+ reductions (Figure 5)f o rb o t h
methanolic and aqueous extracts for all dosages. This infers
that both extracts diﬀerentially inhibit lipid peroxidation
by virtue of their varying degrees of free radical quenching
potential.
3.5.XTTAssay. Boththeextractsdemonstratedconsiderable
cytotoxicity in both celllines, thereby indicating the presence
of anti-cancer metabolites. Table 1 presents the IC50 values
fortheaqueousandmethanolicextractsofR.emodiinMDA-
MB-435S and Hep3B cell lines.Evidence-Based Complementary and Alternative Medicine 5
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Figure 5: Methanolic and aqueous extracts of R. emodi rhizome
inhibit lipid peroxidation by virtue of their radical scavenging
potential. Signiﬁcant correlations (P < .05) observed between
%LPI and (a) %DRSA, (b) %HRSA, (c) percentage Fe3+ reducing
potential.
Table 1:IC50 valuesofaqueousandmethanolicextractsofR.emodi
inMDA-MB-435SandHep3BcelllinesasdeterminedinXTTassay.
MDA-MB-435S (μgml −1)H e p 3 B ( μgml −1)
Aqueous extract 33.00 ± 8.31 85.58 ± 3.60
Methanolic extract 8.50 ± 3.70 38.43 ± 6.00
OC DNA
SC DNA
LIN DNA
CC R SA SM
Figure 6: Eﬀect of R. emodi rhizome extracts (50μg) on the
protection of supercoiled DNA (pBR322) against oxidative damage
causedbyUV-photolysedH2O2 (3%).C=untreatednon-irradiated
DNA (control); CR = untreated UV-irradiated DNA (control);
SA = UV-irradiated, aqueous extract treated; SM = UV-irradiated,
methanolic extract treated; SC DNA = supercoiled DNA; OC DNA
= open circular DNA; LIN DNA = linear DNA.
3.6. DNA Damage Inhibition Eﬃciency. Figure 6 shows
the electrophoretic pattern of pBR322 DNA following
UV-photolysis of H2O2 in absence (in controls C and
CR) and presence (in samples SA and SM) of the extracts.
Control pBR322 (C) showed two bands on agarose gel
electrophoresis. The faster moving band represented
the native form of supercoiled circular DNA (SC DNA)
and the slower moving faint band corresponded to the
open circular form (OC DNA) [19]. The aqueous extract
displayed considerably protective activity in comparison to
the methanolic extract which did not show any protective
activity. UV-photolysis of H2O2 in CR damaged the entire
DNA (no bands visible). SA did not show a SC DNA band;
instead, it developed a new faint intermediate band for
linear DNA (LIN DNA) as a result of free radical damage
to SC DNA. On the other hand, the methanolic extract
did not show any protective activity. The results infer that
UV-photolysed H2O2 (3%) treatment of pBR322 obliterated
the entire DNA (in CR), while 50μg of the aqueous extract
gave partial protection against DNA damage.
It is, however, an interesting observation that albeit
identical •OH radical scavenging potential of both extracts,
the methanolic extract failed comprehensively to encounter
theeﬀectsofUV-photolysedH2O2-derived •OHradicalsthat
cause oxidative DNA damage. This letdown might be due
to a probable DNA-damaging property of the methanolic6 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Relationship between total phenolic content of methanolic and aqueous extracts of R. emodi rhizome and their (a) %DRSA,
( b )% H R S A ,( c )% L P I ,( d )p e r c e n t a g eF e 3+ reducing potential. All parameters show strong and signiﬁcant positive correlation with total
phenolic content (at P < .05) for both extracts.
Table 2:Totalphenoliccontentsofmethanolicandaqueous extract
of R. emodi rhizome.
Concentration (μg) GAE ± SD (μg)(a)
Methanolic extract Aqueous extract
50 13.33 ± 0.18 7.68 ± 0.073
100 20.96 ± 0.23 9.94 ± 0.016
150 28.98 ± 0.38 12.13 ± 0.092
200 36.44 ± 0.26 14.30 ± 0.016
250 36.99 ± 0.53 14.71 ± 0.028
(a)GAE ± SD at 95% conﬁdence interval.
extract per se. Cytotoxicity of the methanolic extract, as
already observed in this study, is about three to four times
more than that of aqueous extract (Table 1). Such extensive
cytotoxicity of the methanolic extract might be hypothesized
to be a probable function of its DNA-damaging capacity.
3.6.1. Estimation of Total Phenolic Content. Table 2 shows
the total phenolic contents in the methanolic and aqueous
extracts expressed as GAE (in micrograms). The results
obtained in all antioxidant assays showed statistically sig-
niﬁcant diﬀerence between the methanolic and aqueous
extracts at P < .05. Correlation and regression analyses
were performed to check whether the polyphenols in the
extracts are responsible for these activities. Total phenolic
content of both extracts showed signiﬁcant and strong
positive correlation (P < .05) with free radical (DPPH• andEvidence-Based Complementary and Alternative Medicine 7
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Figure 8: Hypothetical diagram representing the modes of action of R. emodi rhizome extracts as an anti-cancer agent. (a) Progression
of cancer through ROS generation, and consequent secondary mutations, angiogenesis and metastasis. (b) Rheum emodi rhizome extracts
prevents cancer progression through cytotoxicity and antioxidant potential.
Table 3: Major phenolic compounds identiﬁed in the methanolic extract of R. emodi rhizome by HPLC.
Phenolic compounds λ(a) (nm) ETR
(b) (min) RTR
(c) (min)
β-Resorcylic acid 250 10.896 10.9
Daidzein-8-O-glucoside (puerarin) 250 19.703 20.1
Daidzein 250 63.828 64.1
(+)-Taxifolin 280 26.696 26.7
Quercetin 370 75.008 75.5
Flavonol 370 91.337 91.5
(a)Wavelenghth for determination.
(b)Analysis retention times.
(c)Reference retention times [21].
•OH) scavenging eﬃciencies, %LPI and %Fe3+ reductions
(Figure 7). These results suggest a probable paramount role
that the polyphenolic constituents of the extracts might
play in free radical neutralization and lipid peroxidation
inhibition.
3.6.2. HPLC Analysis. Due to the diversity and complexity
of natural phenolic compounds, it is diﬃcult to characterize
every compound present in the crude extract to elucidate
its structure [23]. Major types of phenolic compounds were
determined in the two extracts of R. emodi by HPLC analysis.
A library of the analytical characteristics (λmax,r e t e n t i o n
time, determining λ, slope and limit calibration) of more
than 100 phenolic standards established by Sakakibara et al.
[21] was used as a reference for compound identiﬁcation.
Table 3 shows the phenolic compounds identiﬁed in the
methanolic extract of R. emodi rhizome along with the
respective retention times (Rt). Both aqueous and methano-
lic extracts also contained unknown compounds evident
from the HPLC data whose characterization is in prospect.
4. Discussion
Aqueous and methanolic extracts of R. emodi showed
promisingantioxidantactivityinalltheexperimentalmodels
used. Both extracts were found to have a dosage-dependent
increase in their antioxidant potentials with varying degrees
of eﬃciencies. The diﬀerential scavenging activities of the
extracts may be attributed to the varying mechanisms
of radical scavenging in these assays. The extracts were
observed to be good scavengers of hydroxyl radical, which
is involved in DNA crosslinkings and strand breaks, and
is considered to be one of the quick initiators of lipid
peroxidation [24]. The ability of the extracts to quench
hydroxyl radicals might directly relate to the prevention of
lipid peroxidation. It can be inferred that the extracts might8 Evidence-Based Complementary and Alternative Medicine
prevent reactive radical species from damaging biomolecules
such as lipoproteins, polyunsaturated fatty acids, DNA,
amino acids, proteins and sugars in biological systems
[25].
Both extracts showed concentration-dependent cytotox-
icity when tested in each of the two cancer cell lines. Accord-
ing to the American National Cancer Institute, the IC50
value to consider a crude extract promising for development
of anti-cancer drug(s) is lower than a limit threshold of
30μg/ml [26]. The extracts can thus serve as potential source
for anti-cancer compounds. The aqueous extract, on the
other hand, although has lower potential as a cytotoxin,
shows considerable degree of DNA protection against oxida-
tive damage, while its methanolic counterpart holistically
lacks this property. These diﬀerences can be attributed to the
presence of diﬀerential protective metabolites eluted out in
the two solvents, and also due to factors like stereoselectivity
and/or solubility of the two extracts [27]. Both extracts were
therefore found to have promising potential towards the
developmentofdrugsthatmightbeusedtotargettumorsfor
chemoprevention/chemotherapy to check neoplastic growth
and malignancy.
A signiﬁcant (P < .05) positive correlation was extrapo-
lated between the results of the assay for estimation of total
phenolic content and those investigating other therapeutic
parameters. In view of this, HPLC analysis was performed
to identify some of the major phenolic compounds in both
extracts. However, we accomplished in identifying major
polyphenols only in the methanolic extract.
The antioxidant, cytotoxicity and DNA protection abili-
ties of the extracts render them suitable to be considered as a
source for the development of anti-cancer drugs (Figure 8).
In tumor cells, ROS is produced extensively, which thereby
increases levels of certain growth factors and enzymes like
metalloproteinases (MMPs) which promote angiogenesis,
and also elevates the risk of metastasis and development
of secondary tumors [28]. Antioxidant properties of the
extracts might therefore prevent progression of cancer;
while the cytotoxic potential, on the other hand, might be
used against cancer cells, thereby directing them towards
apoptosis and cell death. DNA protection property might
hold good in inhibiting secondary mutations in progressive
tumor tissues.
5. Conclusion
Rhizome of R. emodi might be a potential source for anti-
cancer metabolites which can be mustered for the develop-
mentofeﬀectivecancerdrugs.Isolationandcharacterization
of compounds from R. emodi rhizome extracts are in
prospect.
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